52 related articles for article (PubMed ID: 12396540)
1. Financial situation of people living with HIV in Europe.
Schrooten W; Dreezen C; Borleffs J; Dijkgraaf M; Borchert M; De Graeve D; Hemmer R; Fleerackers Y; Colebunders R;
Int J STD AIDS; 2002 Oct; 13(10):698-701. PubMed ID: 12396540
[TBL] [Abstract][Full Text] [Related]
2. The use of complementary and alternative medicine by persons with HIV infection in Europe.
Colebunders R; Dreezen C; Florence E; Pelgrom Y; Schrooten W;
Int J STD AIDS; 2003 Oct; 14(10):672-4. PubMed ID: 14596770
[TBL] [Abstract][Full Text] [Related]
3. The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia.
Riyarto S; Hidayat B; Johns B; Probandari A; Mahendradhata Y; Utarini A; Trisnantoro L; Flessenkaemper S
Health Policy Plan; 2010 Jul; 25(4):272-82. PubMed ID: 20156918
[TBL] [Abstract][Full Text] [Related]
4. Income and employment of people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
Conover CJ; Arno P; Weaver M; Ang A; Ettner SL
J Ment Health Policy Econ; 2006 Jun; 9(2):71-86. PubMed ID: 17007485
[TBL] [Abstract][Full Text] [Related]
5. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
[TBL] [Abstract][Full Text] [Related]
6. Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study.
Dray-Spira R; Lert F;
AIDS; 2007 Jan; 21 Suppl 1():S29-36. PubMed ID: 17159584
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatments used among adults with HIV infection in Europe.
Colebunders R; Schrooten W; Dreezen C; Baratta C; Florence E; Finazzi R; Wilkins E; Hemmer R; Fleerackers Y; Andragetti R; Borchert M;
AIDS Care; 2001 Feb; 13(1):5-14. PubMed ID: 11177461
[TBL] [Abstract][Full Text] [Related]
8. Socio-economic factors and health-related quality of life in adults living with HIV.
Worthington C; Krentz HB
Int J STD AIDS; 2005 Sep; 16(9):608-14. PubMed ID: 16176627
[TBL] [Abstract][Full Text] [Related]
9. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
10. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
11. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.
Dray-Spira R; Spire B; Heard I; Lert F;
AIDS; 2007 Jan; 21 Suppl 1():S5-12. PubMed ID: 17159588
[TBL] [Abstract][Full Text] [Related]
13. Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy.
Delpierre C; Cuzin L; Lauwers-Cances V; Datta GD; Berkman L; Lang T
Sex Transm Infect; 2008 Jun; 84(3):183-6. PubMed ID: 18192292
[TBL] [Abstract][Full Text] [Related]
14. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicine in HIV-infected subjects.
Agnoletto V; Chiaffarino F; Nasta P; Rossi R; Parazzini F
Complement Ther Med; 2006 Sep; 14(3):193-9. PubMed ID: 16911899
[TBL] [Abstract][Full Text] [Related]
16. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.
Henderson M; Safa F; Easterbrook P; Hotopf M
HIV Med; 2005 Sep; 6(5):347-52. PubMed ID: 16156883
[TBL] [Abstract][Full Text] [Related]
17. Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya.
Sarna A; Luchters SM; Geibel S; Kaai S; Munyao P; Shikely KS; Mandaliya K; van Dam J; Temmerman M
Int J STD AIDS; 2008 Feb; 19(2):85-9. PubMed ID: 18334059
[TBL] [Abstract][Full Text] [Related]
18. Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services.
Cooper D; Moodley J; Zweigenthal V; Bekker LG; Shah I; Myer L
AIDS Behav; 2009 Jun; 13 Suppl 1():38-46. PubMed ID: 19343492
[TBL] [Abstract][Full Text] [Related]
19. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
20. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy.
van Kooten Niekerk NK; Knies MM; Howard J; Rabie H; Zeier M; van Rensburg A; Frans N; Schaaf HS; Fatti G; Little F; Cotton MF
J Trop Pediatr; 2006 Feb; 52(1):3-11. PubMed ID: 15947012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
